CRNC - Hot Stocks: NUE guidance; VIR Omicron hope; CRNC loses CEO; RRD takes bid; AI stock repurchase

A disappointing forecast sent Nucor (NYSE:NUE) reeling on Wednesday, one of the standout decliners in midday trading. Cerence (NASDAQ:CRNC) also posted a double-digit percentage decline, pulled down by the sudden departure of its CEO. The list of midday decliners also included R.R. Donnelley (NYSE:RRD). The stock gave back some of its recent gains on news that it has accepted an offer in the bidding war to take the company private. Looking at some of the top intraday gainers, Vir Biotechnology (NASDAQ:VIR) posted a notable advance. Shares got a lift from evidence that its anti-COVID product works against the Omicron variant. Elsewhere, a stock repurchase plan stirred buying interest in C3.ai (NYSE:AI). Decliners Nucor (NUE) showed an intraday decline of 11% after it provided soft guidance for Q4. The steel maker predicted EPS of $7.65-$7.75 for the quarter, compared to the $8.12 that analysts were predicting. In making the forecast, the

For further details see:

Hot Stocks: NUE guidance; VIR Omicron hope; CRNC loses CEO; RRD takes bid; AI stock repurchase